Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced management participation in three upcoming investor ...

Q4 2024 Earnings Call Transcript February 13, 2025 Operator: Good morning, and welcome to Agios’ Fourth Quarter 2024 ...

Despite promising Phase 3 results, safety concerns, namely liver injury, have impacted Agios stock and could affect Pyrukund's approval and market adoption. Read the full report here.

The result transformed itself into Black Health Matters, an online health promotion and disease management platform that will ...

Saint Louis University (SLU) is celebrating a noteworthy accomplishment this February: becoming an R1 institution. The ...

Anxieties about malingering or feigned illness are at least a thousand years old in the West”, argued public health ethicist ...

A new effort is underway to legalize not just medical marijuana but recreational use, too. But is that the best route forward ...

More local governments are declaring a dengue outbreak. The Quezon City Government was the first to announce an uptick in ...

The high cost of sickle cell gene therapies is pushing private insurers and Medicaid programs to develop new payment models.

In December 2023, through the development efforts of CRISPR Therapeutics and Vertex Pharmaceuticals, their decades-long ...

Lawyers described a lifetime of pain management that ultimately led to the death of 20-month-old Reign Nelson.